Matt Giles - Email & Phone Number

VP, New Products at Roivant Sciences

Matt Giles is based out of Brooklyn, New York, United States and works at Roivant Sciences as VP, New Products.

Matt Giles's Contact Information

Matt Giles's Work email

m*****@roiva***.com

Valid

Latest update

September 16, 2025

Location

Brooklyn, New York, United States

Matt's current employer

Roivant Sciences

Description

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – ni...

Website

roivant.com

HQ Location

New York, New York, United States

Number of employees

201-500

Industry

Biotechnology Research

Latest update

May 1, 2024

Read about Roivant Sciences

Frequent questions about Matt Giles

What company is Matt Giles working for?

Matt Giles works for Roivant Sciences.

What is Matt Giles's function at Roivant Sciences?

Matt Giles is VP, New Products at Roivant Sciences.

Where is Matt Giles based?

Matt Giles is based out of Brooklyn, New York, United States.

What is Matt Giles's work email address?

Matt Giles's professional email address is m*****@roiva***.com

Who are Matt Giles's co-workers?

Matt Giles's colleagues are Regina Sav, Ricky Mei, Alicia Collins, Matthew Gline, Drew Fromkin, Stephanie Griffin, Benjamin Zimmer, Mayukh Sukhatme, Eric Venker, Vivek Ramaswamy, Hong Natarajan, Nanxiang Ge, Markus Rohrwild, Cheryl Blasie, Jason Imbriglio, Jesus Izaguirre, Jian-ping Tang, Jason Chamberlain, Jeffrey Kalmus, Artem Evdokimov, Sara Núñez-Garcia, Jeffrey Yuan, Jon Kluft, Nik Khetarpal, Keith Haan, Michael Robin, Damien Glutsch, Eric Valeur, Trevor Cardwell, Shingai Majuru, Raj Punwaney, Paul Oppold, Roger Sidhu, Navneet Alag, Alex Gasner.

Matt's co-workers

Regina Sav

Senior Director, Office of the CEO

Ricky Mei

Chief Executive Officer

Alicia Collins

Executive Assistant To Chief Executive Officer

Matthew Gline

Chief Executive Officer

Drew Fromkin

Chief Executive Officer Proteovant, Vant Portfolio Operating Partner (Roivant Sciences)

Stephanie Griffin

VP, Special Projects, Office of CEO

Benjamin Zimmer

President, Roivant Health

Mayukh Sukhatme

President and Chief Investment Officer

Eric Venker

President and Chief Operating Officer

Vivek Ramaswamy

Founder

Hong Natarajan

Vice President Program Management and Clinical Operations

Nanxiang Ge

VP, Head of Biometrics and Data Management

Markus Rohrwild

Vice President Governance

Cheryl Blasie

Vice President, Head of Quality

Jason Imbriglio

VP - Head of Discovery Chemistry, Roivant Discovery

Jesus Izaguirre

Vice President Advanced Simulations

Jian-ping Tang

Vice President, Head of Clinical Pharmacology

Jason Chamberlain

Vice President - Head of Nonclinical Development

Jeffrey Kalmus

VP, Head of Strategic Finance

Artem Evdokimov

Vice President Biochemistry, Biophysics & Biology

Sara Núñez-Garcia

Partner - VP Investments

Jeffrey Yuan

Vice President and Head of Regulatory Affairs

Jon Kluft

VP Business Development

Nik Khetarpal

Keith Haan

Vice President, Investments

Michael Robin

Vice President, Program Management & Operations

Damien Glutsch

VP Finance

Eric Valeur

VP Research, Head of Drug Discovery

Trevor Cardwell

Senior Cloud/Network Engineer

Shingai Majuru

Vice President, Head of CMC, Small Molecule Development

Raj Punwaney

Vice President, Clinical Development

Paul Oppold

Vice President, Investments

Roger Sidhu

Executive Vice President, Head of Research and Development and Chief Medical Officer

Navneet Alag

Vice President - Vant Governance and Strategy

Alex Gasner

Executive Vice President, Roivant Health

Browse & Connect

Browse companies

Our company index contains hundreds of thousands of businesses.

a b c d e f g h i j k l m n o p q r s t u v w x y z

Wiza does not guarantee or claim any of the information found on this public directory to be 100% accurate or up to date.Information found here is gathered from a variety of online and offline sources.If you wish to exclude your personal data from this public directory please fill out the optout form.